Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 255 is a pseudogene annotated in the human genome. Pseudogenes are DNA sequences similar to functional genes but are generally considered nonfunctional due to accumulated mutations, lack of regulatory elements, or incomplete sequences. RN7SK pseudogene 255 shares sequence similarity with the 7SK small nuclear RNA gene but is not transcribed into a functional RNA or protein. There is no evidence linking this pseudogene to any biological function, disease process, or therapeutic intervention. The *functional* 7SK small nuclear RNA (RN7SK) is a highly conserved non-coding RNA that regulates transcription by controlling the activity of positive transcription elongation factor b (P-TEFb), with links to several biological processes and diseases. However, *pseudogenes* such as RN7SKP255 do not share these properties and are not considered receptors, enzymes, or drug targets. If information about the **true 7SK RNA or its associated ribonucleoprotein (RNP)** is desired, clarification should be made, as "RN7SKP255" refers specifically to the pseudogene, not the functional molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 255 (RN7SKP255).